Centrexion Therapeutics centrexion.com


Public lists: Pharma Startups (4732)

Centrexion Therapeutics is focused on developing new treatments for moderate to severe chronic pain that address the safety and efficacy gaps in the current treatment paradigm.

Centrexion Therapeutics is focused on developing new treatments for moderate to severe chronic pain that address the safety and efficacy gaps in the current treatment paradigm.

Company (Alive / Active)

Phone: 617-837-6911

Fax:

200 State Street
6th Floor
Boston, 02109
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Centrexion Therapeutics $140.9M Jan 2, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Centrexion Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
InterWest PartnersVenture CapitalMenlo Park, California, United StatesSeries D, Series C, Series A - II, Series A
Clough GlobalAsset/Investment ManagementDenver, Colorado, United StatesSeries D
ArrowMark PartnersAsset/Investment ManagementDenver, Colorado, United StatesSeries D
EFung CapitalOtherSeries D
6 Dimensions CapitalVenture CapitalShanghai, Shanghai, ChinaSeries D
See all 9 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Somatostatin receptor subtype 4 (sstr4) agonists May 18, 2016 Oct 17, 2017 Patent
Ccr2 receptor antagonists and uses thereof Apr 24, 2014 Jun 06, 2017 Patent
(cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles May 16, 2014 May 16, 2017 Patent
Somatostatin receptor subtype 4 (sstr4) agonists May 12, 2014 Jun 21, 2016 Patent
High concentration local anesthetic formulations Feb 21, 2012 Jun 21, 2016 Patent
See all 11 patents